245 related articles for article (PubMed ID: 26491350)
1. Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review.
Chen D; Zhang Y; Shi F; Li M; Zhu H; Kong L; Yu J
Onco Targets Ther; 2015; 8():2767-70. PubMed ID: 26491350
[TBL] [Abstract][Full Text] [Related]
2. Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients.
Chen D; Zhang Y; Shi F; Zhu H; Li M; Luo J; Chen K; Kong L; Yu J
Oncotarget; 2016 Aug; 7(32):52436-52441. PubMed ID: 27203219
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion.
He D; Guo Z; Xie Z; Zhang Y; Deng Q; Yang H
Can Respir J; 2022; 2022():6763625. PubMed ID: 36353447
[TBL] [Abstract][Full Text] [Related]
4. Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion.
Chen D; Song X; Shi F; Zhu H; Wang H; Zhang N; Zhang Y; Kong L; Yu J
Oncotarget; 2017 May; 8(21):35262-35271. PubMed ID: 27823984
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Observation of Gefitinib with Pericardial Perfusion for
Advanced Non-small Cell Lung Cancer].
Wang X; Chen J; Yao J; Guo R
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):37-42. PubMed ID: 29357971
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of 5-fluorouracil sustained-release particles in 81 malignant pericardial effusion patients.
Ji YL; Li RZ; Xue LF; Li P; Liang XH; Dong L; Gao Y; Cui WC; Pang MX
Kaohsiung J Med Sci; 2015 Feb; 31(2):96-101. PubMed ID: 25645988
[TBL] [Abstract][Full Text] [Related]
7. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
[TBL] [Abstract][Full Text] [Related]
8. A case of advanced lung cancer with malignant pericardial effusion treated by intrapericardial Cinobufacini injection instillation.
Sun T; Zhang Y; Shen Y; Hu K; Zuo M
Biosci Trends; 2014 Aug; 8(4):235-9. PubMed ID: 25048980
[TBL] [Abstract][Full Text] [Related]
9. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer.
Tomkowski WZ; Filipecki S
Lung Cancer; 1997 Mar; 16(2-3):215-22. PubMed ID: 9152952
[TBL] [Abstract][Full Text] [Related]
10. [A case of malignant pericardial effusion due to breast cancer successfully controlled by intrapericardial chemotherapy using pirarubicin].
Fujito T; Maeura Y; Shimoda M; Hojo S; Yano Y; Matsunaga S
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1757-9. PubMed ID: 11708027
[TBL] [Abstract][Full Text] [Related]
11. Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study.
Kotake M; Imai H; Kaira K; Fujisawa T; Yanagita Y; Minato K
Cancer Chemother Pharmacol; 2019 Sep; 84(3):655-660. PubMed ID: 31250155
[TBL] [Abstract][Full Text] [Related]
12. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
13. Malignant pericardial effusion in breast cancer: terminal event or treatable complication?
Swanepoel E; Apffelstaedt JP
J Surg Oncol; 1997 Apr; 64(4):308-11. PubMed ID: 9142188
[TBL] [Abstract][Full Text] [Related]
14. Intrapericardial mitomycin C for the management of malignant pericardial effusion secondary to gastric cancer: case report and review.
Kohnoe S; Maehara Y; Takahashi I; Saito A; Okada Y; Sugimachi K
Chemotherapy; 1994; 40(1):57-60. PubMed ID: 8306816
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion.
Lee LN; Yang PC; Chang DB; Yu CJ; Ko JC; Liaw YS; Wu RG; Luh KT
Thorax; 1994 Jun; 49(6):594-5. PubMed ID: 8016797
[TBL] [Abstract][Full Text] [Related]
16. [Malignant pericardial effusion--a sign of unfavorable prognosis?].
Holdener EE; Ryser DH; Schaermeli K; Spieler P; Angehrn W; Reutter FW; Gloor F; Senn HJ
Schweiz Med Wochenschr; 1986 Mar; 116(12):366-70. PubMed ID: 3961455
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion.
Wiyeh AB; Ochodo EA; Wiysonge CS; Kakia A; Awotedu AA; Ristic A; Mayosi BM
Int J Cardiol; 2018 Jan; 250():223-228. PubMed ID: 29107356
[TBL] [Abstract][Full Text] [Related]
18. Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer.
Moriya T; Takiguchi Y; Tabeta H; Watanabe R; Kimura H; Nagao K; Kuriyama T
Br J Cancer; 2000 Oct; 83(7):858-62. PubMed ID: 10970685
[TBL] [Abstract][Full Text] [Related]
19. Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review.
Lambert A; Salleron J; Kieffer A; Raymond P; Geoffrois L; Gavoille C
Bull Cancer; 2020; 107(7-8):756-762. PubMed ID: 32513434
[TBL] [Abstract][Full Text] [Related]
20. Nomogram construction for predicting survival of patients with non-small cell lung cancer with malignant pleural or pericardial effusion based on SEER analysis of 10,268 patients.
Tian T; Zhang P; Zhong F; Sun C; Zhou J; Hu W
Oncol Lett; 2020 Jan; 19(1):449-459. PubMed ID: 31897158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]